Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cellebrite DI Q2 Adj. EPS $0.12 Beats $0.10 Estimate, Sales $113.276M Beat $112.206M Estimate

Author: Benzinga Newsdesk | August 14, 2025 06:00am
Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.10 by 15.38 percent. This is a 20 percent increase over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $113.276 million which beat the analyst consensus estimate of $112.206 million by 0.95 percent. This is a 18.35 percent increase over sales of $95.714 million the same period last year.

Posted In: CLBT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist